🔎 Trials Near Me

Utama › Kolitis Ulseratif › Texas › Tyler

Kajian klinikal Kolitis Ulseratif di Tyler, TX

14 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi dalam dan sekitar Tyler (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Mengambil pesertaFasa 3
  • Tyler Research Institute ( Site 0294), Tyler
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06651281

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 2
  • Tyler Research Institute, Tyler
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • Xencor Investigative Site, Tyler
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06619990

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 2
  • Site US-004, Tyler
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Tyler Research Institute, LLC, Tyler
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Mengambil pesertaFasa 3
  • Tyler Research Institute, Tyler
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Mengambil pesertaFasa 2
  • Tyler Research Institute, Tyler
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 2
  • Tyler Research Institute, Tyler
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Mengambil pesertaFasa 4
  • Tyler Research Institute, LLC, Tyler
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Tyler Research Institute, LLC - Site Number: 8400095, Tyler
Umur 16 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Tyler Research Institute, LLC, Tyler
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Mengambil pesertaFasa 3
  • Tyler Research Institute, LLC - Site Number: 8400095, Tyler
Umur 16 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07184996

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Mengambil pesertaFasa 2
  • Tyler Research Institute, LLC, Tyler
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06764615

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mengambil pesertaFasa 2
  • Mirador Therapeutics Selected Site, Tyler
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

Kajian Kolitis Ulseratif di bandar lain

Kajian lain di Tyler

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.